Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
389
-
Total 13F shares, excl. options
-
33.1M
-
Shares change
-
-4.02M
-
Total reported value, excl. options
-
$4.73B
-
Value change
-
-$715M
-
Put/Call ratio
-
1.93
-
Number of buys
-
174
-
Number of sells
-
-215
-
Price
-
$143.07
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q4 2021
529 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q4 2021.
NOVAVAX INC - Common Stock (NVAX) has 389 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.1M shares
of 160M outstanding shares and own 20.64% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.9M shares), BlackRock Inc. (4.4M shares), RA CAPITAL MANAGEMENT, L.P. (2.1M shares), STATE STREET CORP (1.9M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.26M shares), HSBC HOLDINGS PLC (1.01M shares), GEODE CAPITAL MANAGEMENT, LLC (983K shares), MORGAN STANLEY (956K shares), Capital World Investors (875K shares), and JANE STREET GROUP, LLC (650K shares).
This table shows the top 389 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.